Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

ENT H&N > H&N Lymphomas of the head and neck > Flashcards

H&N Lymphomas of the head and neck Flashcards

1
Q

Where are the most common location for extranodal lymphoma in the head and neck?

A

Waldeyer ring. Nasopharynx > tonsil > tongue base

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What structures in the head and neck can be

involved with lymphoma?

A

Essentially any; paranasal sinuses, salivary glands, thyroid,
lymph nodes, Waldeyer ring, larynx, and the orbit are all
possible sites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In addition to the lymph nodes, what anatomical
sites should be considered for involvement in a
patient with extranodal tonsillar non-Hodgkin
lymphoma?

A

About 20% of patients with tonsillar non-Hodgkin lympho-

ma have gastrointestinal tract involvement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What percentage of patients with extranodal

lymphoma will have associated nodal disease?

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Between Hodgkin lymphoma and non-Hodgkin lymphoma, which is more likely to involve extra-
nodal disease at diagnosis?

A

Non-Hodgkin lymphoma (30% extranodal presentation)

more than Hodgkin lymphoma (5%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the primary risk factor for parotid mucosa-

associated lymphoid tissue (MALT) lymphoma?

A

Sjögren syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the primary risk factor for thyroid MALT

lymphoma?

A

Hashimoto thyroiditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the second most common malignancy in

the head and neck?

A

Lymphoma; it makes up 15 to 20% of all head and neck

cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the indolent non-Hodgkin lymphomas?

A

Follicular, B-cell chronic lymphocytic lymphoma, marginal B-cell, lymphoplasmacytic (Waldenstrom macroglobuline-
mia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the aggressive non-Hodgkin lymphomas?

A

Diffuse large B-cell, peripheral T-cell, mantle cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the highly aggressive non-Hodgkin

lymphomas?

A

Burkitt, precursor T- and B-cell lymphoblastic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the endemic form of Burkitt lymphoma.

A

A form of non-Hodgkin lymphoma that arises from EBV genomic integration and t(8;14) translocation that constitutively activates c-myc, causing mandible tumors among children of central Africa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are common markers for B-cell lymphoma?

A

CD20, CD22, and CD79a are strongly positive in most B-cell lymphomas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the typical histopathology of Hodgkin

disease?

A

Reed-Sternberg cells, which contain two large nuclear lobes

with pale chromatin and distinct eosinophilic nucleoli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe tumor lysis syndrome.

A

The development of hypocalcemia, hyperkalemia, hyperuricemia, hyperphosphatemia, and acute renal failure in the days after initiation of chemotherapy for aggressive
lymphoma. Death from cardiac arrhythmias can result.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are B-symptoms as they pertain to lymphoma?

A

Fever > 38°C, > 10% weight loss in 6 months, night sweats

17
Q

Are B-symptoms more common with Hodgkin

lymphoma or non-Hodgkin lymphoma?

A

Hodgkin lymphoma

18
Q

How common are B-symptoms in patients with

extranodal non-Hodgkin lymphoma?

A

Approximately 20% of patients with extranodal non-

Hodgkin lymphoma have B symptoms.

19
Q

What are the findings for lymphoma on T1- and
T2-weighted MRI with and without gadolinium
enhancement?

A

T1-low signal intensity and T2-low to high signal intensity.
Gadolinium uptake is variable but usually demonstrates low
enhancement.

20
Q

How is FNA limited in diagnosing lymphoma?

A

FNA results yield cytology, which does not provide infor-

mation on nodal architecture (follicular vs. diffuse).

21
Q

Describe the Ann Arbor staging system for

lymphoma.

A

● Stage I: single lymph node region or single extralym-
phatic organ
● Stage II: Two or more lymph node regions or extra-
lymphatic organs on one side of the diaphragm
● Stage III: Involvement on both sides of the diaphragm
● Stage IV: Diffuse or disseminated involvement of 1 or
more extralymphatic organs with or without node
involvement

22
Q

What is the mechanism of action of rituximab?

A

A monoclonal antibody against CD20, which is a B-cell marker.

23
Q

What agents are included in CHOP therapy?

A

● Cyclophosphamide (Cytoxan)
● Hydroxydaunorubicin (doxorubicin)
● Oncovin (vincristine)
● Prednisone

24
Q

What is the primary treatment modality for localized (stage I or II) low-grade lymphoma?

A

Radiation therapy, to which chemotherapy is often added in

more advanced disease.

25
Q

What is the primary role of surgery for head and

neck non-Hodgkin lymphoma?

A

Surgery is useful for establishing diagnosis. Further treatment is better served with radiation and chemotherapy.

ENT H&N (24 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions